FAPI亲和性非恶性PET/CT表现:一项快速系统综述
动脉摄取(如斑块相关,n=1178,49%)最常见,其次为退行性和创伤性骨关节病变(n=147,6%)、关节炎(n=92,4%)、炎症/感染/纤维化/IgG4相关疾病(n=157,7%)、炎症/反应性淋巴结(n=121,5%)和结核病变(n=51,2%)等;作者指出大量良性临床病变可显示FAPI摄取,在解读癌症患者FAPI PET/CT时应予以注意。
要点
- 动脉摄取(如斑块相关)是最常见的FAPI亲和性非恶性表现,占49%(n=1178)。
- 炎症/反应性淋巴结(n=121,5%)和结核病变(n=51,2%)可能是肿瘤分期的潜在陷阱。
- 退行性和创伤性骨关节病变(n=147,6%)及关节炎(n=92,4%)也常见FAPI摄取。
核心结论
- 本综述概述了迄今报告的FAPI亲和性非恶性PET/CT表现,大量良性临床病变可显示FAPI摄取,在解读癌症患者FAPI PET/CT时应予以注意。
研究设计与样本
- 系统检索PubMed、Embase和Web of Science至2022年4月发表的研究,纳入使用68Ga或18F标记FAPI示踪剂的人体原创同行评议英文文章,排除无原始数据及信息不足的研究。
- 共检索到1178篇论文,最终纳入108项研究,其中病例报告80项(74%),队列研究28项(26%)。
主要发现
- 退行性和创伤性骨关节病变(n=147,6%)及关节炎(n=92,4%)也常见FAPI摄取。
- 器官的弥漫性或局灶性摄取常见于炎症、感染、纤维化和IgG4相关疾病(n=157,7%)。
- FAPI亲和性炎症/反应性淋巴结(n=121,5%)和结核病变(n=51,2%)已有报告,可能是肿瘤分期的潜在陷阱。
- 牙周炎(n=76,3%)、痔疮(n=47,2%)和瘢痕/伤口愈合(n=35,2%)也表现为FAPI PET/CT局灶性摄取。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Fibroblast activation protein inhibitor (FAPI) is a promising tracer in oncologic positron emission tomography/computed tomography (PET/CT). Numerous studies have demonstrated the superior sensitivity of FAPI PET/CT over fluorodeoxyglucose (FDG) PET/CT in several types of cancer. However, the cancer specificity of FAPI uptake remains understudied, and several cases of false-positive FAPI PET/CT findings have been reported. A systematic search of PubMed, Embase, and Web of Science was conducted for studies published prior to April 2022 reporting nonmalignant FAPI PET/CT findings. We included original peer-reviewed articles of studies in humans using FAPI tracers radiolabeled with 68Ga or 18F that were published in English. Papers without original data and studies with insufficient information were excluded. Nonmalignant findings were presented on a per-lesion basis and grouped according to the type of organ or tissue involved. The search identified a total of 1.178 papers, of which 108 studies were eligible. Eighty studies were case reports (74%), and the remaining 28 were cohort studies (26%). A total of 2.372 FAPI-avid nonmalignant findings were reported, with the most frequent being uptake in the arteries, e.g., related to plaques (n = 1178, 49%). FAPI uptake was also frequently related to degenerative and traumatic bone and joint lesions (n = 147, 6%) or arthritis (n = 92, 4%). For organs, diffuse or focal uptake was often seen in cases of inflammation, infection, fibrosis, and IgG4-related disease (n = 157, 7%). FAPI-avid inflammatory/reactive lymph nodes (n = 121, 5%) and tuberculosis lesions (n = 51, 2%) have been reported and could prove to be potential pitfalls in cancer staging. Periodontitis (n = 76, 3%), hemorrhoids (n = 47, 2%), and scarring/wound healing (n = 35, 2%) also presented as focal uptake on FAPI PET/CT. The present review provides an overview of the reported FAPI-avid nonmalignant PET/CT findings to date. A large number of benign clinical entities may show FAPI uptake and should be kept in mind when interpreting FAPI PET/CT findings in patients with cancer.
引用
- Bentestuen M, Al-Obaydi N, Zacho HD, et al. FAPI-avid nonmalignant PET/CT findings: An expedited systematic review. Semin Nucl Med. 2023. PMID: 36813670. doi:10.1053/j.semnuclmed.2023.02.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。